Mirella
Mirella Dottori, Queensland AU
Patent application number | Description | Published |
---|---|---|
20080255044 | Method of treatment - The present invention relates generally to a method of treatment and in particular a method of treating disorders of the nervous system such as arising from or during disease or injury. The method of the present invention involves manipulating expression of Eph receptors or their functional equivalents to increase or decrease expression or function depending on the condition being treated. | 10-16-2008 |
Mirella Dottori, Victoria AU
Patent application number | Description | Published |
---|---|---|
20120301965 | CELL PROGRAMMING - The present invention is concerned with methods for reprogramming of mammalian somatic cells and in particular to reprogramming of mature mammalian somatic cells into multi-potent precursor cells. | 11-29-2012 |
Mirella Ezban, Copenhagen O DK
Patent application number | Description | Published |
---|---|---|
20090036378 | Use of Factor VIIa or a Tissue Factor Antagonist for Regulating Gene Expression and Cell Migration or Chemotaxis - The present invention relates to use of FVII and/or FVIIa and/or another TF agonist and/or FVIIai and/or another TF antagonist in therapeutic treatment of pathological conditions that can be related to cell migration or treated by specific regulation of cell migration or chemotaxis. | 02-05-2009 |
20090191179 | Use of factor VIIa analogues with increased activity - The invention relates to methods for the treatment of a severely bleeding subject. | 07-30-2009 |
20090191180 | Use of Factor VIIa Analogues with Increased Activity - The invention relates to methods for treatment of bleeding episodes in a subject with thrombocytopenia. | 07-30-2009 |
Mirella Gonzalez-Zulueta US
Patent application number | Description | Published |
---|---|---|
20080226646 | USE OF BIOMOLECULAR TARGETS IN THE TREATMENT AND VISUALIZATION OF TUMORS - The present invention relates to the use of a protein that is differentially expressed in primary brain tumor tissues, as compared to normal brain tissues, as a biomolecular target for tumor treatment therapies. The protein is also expressed in tissues from adenocarcinoma, non-melanoma, and renal carcinoma cells. Immunotherapeutic and immunoimaging agents that specifically bind to an identified brain tumor target protein are provided. The present invention also provides compounds and pharmaceutically acceptable compositions for administration in the methods of the invention. | 09-18-2008 |
Mirella Gwarek, Koeln DE
Patent application number | Description | Published |
---|---|---|
20110250239 | PHARMACEUTICAL AND/OR COSMETIC COMPOSITION FOR TREATING THE SKIN - The present invention concerns the pharmaceutical and cosmetic application of biocolloids, which originate from the mixture of a nanoemulsion and at least one water-soluble plant extract such as an extract from | 10-13-2011 |
Mirella Meyer-Ficca, Waldbockelheim DE
Patent application number | Description | Published |
---|---|---|
20080221058 | Tumor-Specific Vector for Gene Therapy - The invention relates to a vector for the gene therapeutic treatment of tumors, especially in connection with radiotherapy. Said vector is provided with a therapeutic gene in the DNA sequence thereof. The gene is controlled by the promoter for the catalytic subunit of the telomerase or by the promoter for cyclin A. | 09-11-2008 |
20130035287 | TRANSIENT IMMORTALIZATION - The invention relates to a method for transiently immortalizing cells according to which immortalization proteins are introduced into the cells from outside. The invention also relates to a method for producing cells according to which organ-related cells are transiently immortalized by the exogenous supply of immortalization proteins and are remortalized after their expansion. The invention further relates to the cells produced according to the inventive method, to the use of said cells for producing a transplant and to the immortalization proteins used in the method. | 02-07-2013 |
20140186311 | TRANSIENT IMMORTALIZATION - The invention relates to a method for transiently immortalizing cells according to which immortalization proteins are introduced into the cells from outside. The invention also relates to a method for producing cells according to which organ-related cells are transiently immortalized by the exogenous supply of immortalization proteins and are remortalized after their expansion. The invention further relates to the cells produced according to the inventive method, to the use of said cells for producing a transplant and to the immortalization proteins used in the method. | 07-03-2014 |
Mirella Pilone, Milano IT
Patent application number | Description | Published |
---|---|---|
20100163432 | MICROSENSOR FOR DETECTION OF D-AMINO-ACIDS - The instant invention is about a microelectrode, in particular for measuring the concentration of a D-amino acid, said microelectrode comprising means for oxidation of said D-amino acid into at least a compound B, means for optimising the detection of said compound B, and means for reducing interferences, in particular interferences due to the oxidation of other species than compound B; a device comprising such a microelectrode; a method for making such a microelectrode, a method for detecting and/or measuring the concentration of a D-amino-acid in a medium. | 07-01-2010 |
Mirella Virginie, Strasbourg FR
Patent application number | Description | Published |
---|---|---|
20120079768 | CATALYST FOR REFORMING TAR USED IN THE STEAM GASIFICATION OF BIOMASS - A catalyst includes an olivine substrate on which an iron compound layer is deposited, produced by impregnating the olivine substrate with a solution including an iron salt, and then heat-treating. The catalyst is useful for steam-reforming tar, in particular in gaseous media from the steam gasification of biomass. Further, the catalyst can be used alone for catalyzing the steam gasification of organic compounds from biomass while limiting the amount of tar produced in the synthesized gases. | 04-05-2012 |